Zurn Elkay (ZWS) director reports 617-share buy at $46.67
Zurn Elkay Water Solutions (ZWS) reported an insider transaction by Director Thomas D. Christopoul.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Zurn Elkay Water Solutions (ZWS) reported an insider transaction by Director Thomas D. Christopoul. On 10/15/2025, he acquired 617 shares of common stock at $46.67 per share. The filing notes the acquisition reflects payment of director fees in restricted stock units that vested immediately, with payout deferred until six months after his cessation of service as a director.
Following the transaction, he beneficially owned 113,662 shares, held directly. The filing was made by one reporting person.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 617 | $46.67 | $29K |
Footnotes (1)
- F1. Payment of director fees in restricted stock units, which vested immediately, but is not paid out until six months after the Reporting Person's cessation of service as a director.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did Zurn Elkay (ZWS) report?
What is the director’s ownership after the transaction?
What is the form type and who filed it for ZWS?
What was the transaction date for the ZWS insider trade?
AI-generated analysis. How Rhea-AI works. Not financial advice.